Biotechnology Pharmaceutical MedTech

We bridge the gap between complex clinical evidence and strategic execution.

We translate shifting landscape dynamics into a clear, forward-looking roadmap, so pharma and biotech medical teams can stress-test development-to-launch scenarios, mitigate risk early and lead their asset's journey to market with confidence.

Start a conversation See the case studies
  • 20+Years in life sciences
  • 3Focus areas: oncology, hematology and rare diseases
  • 5Network locations across three continents

01Who we are

Life Sciences, since day one.

LatM is a privately owned boutique consulting company, exclusively focused on the Life Sciences industry: pharmaceutical, biotech, diagnostics and MedTech.

02What we do

A problem-first approach to your team’s next decision.

Medical teams often operate in a dynamic environment where the optimal path forward is not always clear. Shifting regulatory decisions, rapid competitor entry, and vast clinical data demand agile and tailored responses. We prioritize your team's operational and strategic challenges before building a solution, converting complex clinical realities into the key insights, strategic roadmaps and defensive plans required to deliver your asset to patients.

Medical

Pillar

Epidemiological & Clinical Landscape

Facing unmapped treatment pathways, unfamiliar therapeutic areas, or limited local and regional epidemiological clarity ahead of market entry.

  • Regional and local epidemiological mapping
  • Real-world treatment patterns assessment
  • Competitive pipeline and landscape identification
  • Unmet medical need and positioning assessment

Pillar

HCP, Patient & Key Accounts Engagement

Seeking to establish reference partnerships and bridge scattered care perspectives across regional accounts.

  • Multidisciplinary HCP mapping and profiling
  • Key accounts identification and profiling
  • PAG strategy and engagement plans
  • Support to cross-specialty care team co-creation and alignment

Pillar

Data & Management Platforms

Experiencing scattered internal and external medical datasets, and security friction around confidential budgets and protocols, without centralization.

  • ISR management dashboards with tiered-permission budget and contract systems
  • One-stop-shop real-time platform for clinical trial landscape intelligence
  • Curated clinical data and RWE comparison platform

Pillar

Medical Excellence

Needing personalized pre-launch preparation, field team dimensioning and execution of launch timelines.

  • Field medical team sizing and structuring models
  • Launch readiness planning
  • Scientific and value communication alignment

Pillar

Medical Intelligence

Requiring constant oversight of clinical data releases, regulatory updates and competitor strategic dynamics to adapt medical positioning.

  • Pre-, live- and post-congress coverage and reporting
  • Continuous primary research with KOLs and PIs of key trials
  • Real-time data readout analysis and strategic interpretation
  • Competitor and regulatory event tracking

Pillar

Advisory Boards & Medical Writing

Requiring direct physician engagement, clinical consensus and a unified scientific narrative across regions, from global to local teams.

  • On-site and virtual Advisory Board design, facilitation and reporting
  • Scientific value story and publication strategy alignment
  • High-impact medical and scientific content generation

03Why LatM

Two decades of life sciences, applied to your next decision.

01 · Experience

More than 20 years of accumulated experience in the life sciences industry.

02 · Trusted partnership

Acting as an extension of your internal team, we join your daily journey to continuously refine processes, challenge ideas and drive mutual growth.

03 · Scientific quality & rigor

Driven by PhD-level experts, we apply scientific precision to translate complex clinical data into solid medical strategies.

04 · Actionable

We translate internal and external dynamics into customized strategic roadmaps and actionable proposals.

05 · Tailor-made

Operational strategies built from a problem-first analysis of your specific clinical, operational and strategic hurdles.

06 · On time

We customize our approaches to your team's timelines, ensuring high-quality execution within tight decision windows.

04Expertise and experience

Focused by choice,
broad by experience.

Primary focus

  • Oncology
  • Hematology
  • Rare Diseases

Other expertise

  • Endocrinology
  • Gastroenterology
  • Immunology
  • Nephrology
  • Vaccines
  • Neurology
  • Ophthalmology
  • Pneumology
  • Hepatitis

05Clients

Who we work with.

Roche, Janssen, MSD, Sanofi, Merck, Medtronic, Amgen, Novartis, Pfizer, AstraZeneca, GSK, Stemline, Bayer, Esteve, Miltenyi Biotec, Merz Therapeutics, JCR Pharmaceuticals

06Case studies

How we do it.

Seven engagements, each with the problem it started from, the work we did and the ground it gained.

DLBCL · Hematology

Curated Medical Platform

Challenge

  • Scattered clinical trial information across internal and external sources
  • Limited knowledge about key competitors
  • Expansion to new therapeutic areas

Solution

  • One-stop-shop for all clinical trials information
  • Automation of timelines, landscapes, data tables and other outputs
  • Integration of APIs, medical platform information and primary research intel

Impact

  • 80% workload operational savings via automated trial reporting
  • Centralized trial data in one real-time and dynamic platform
  • Accelerated entry into new therapeutic areas

Medullary Thyroid Cancer · Rare Diseases

Advisory Board

Challenge

  • Recent rare disease drug acquisition and national market re-entry
  • Identification of the achievable positioning within the landscape
  • Limited engagement with the relevant stakeholders

Solution

  • Landscape clinical data review and comparison
  • Identification of national KOLs with previous experience of the drug
  • Intimate 3-KOL advisory setup optimized for candid strategic exchange

Impact

  • Defined positioning to accelerate national drug re-entry
  • Built high-trust relationships with top experienced national KOLs
  • Unlocked actionable insights tailored to local market realities

Multiple Myeloma · Hematology

ISR Medical Dashboard

Challenge

  • ISR data fragmented in internal spreadsheets with no central platform
  • Classified budget information restricting folder access and sharing
  • High operational friction tracking timelines, budgets and contracts

Solution

  • Web-based dashboard linked to a single shared data source controlled by the client's team
  • Tiered permissions securing sensitive budget and study files
  • Intuitive UI/UX with smart filtering and exportable information for daily workflows

Impact

  • Improved time savings achieved via automated reporting
  • Expanded trial visibility while keeping strict data control
  • Single source of truth established for all ISR studies

Solid Tumors · Oncology

Regional Biosimilar Threat

Challenge

  • Imminent biosimilar entry threatening the core franchise across the region
  • Limited visibility on competitor launch timing and scientific quality
  • Risk of rapid market share loss and price erosion in key markets

Solution

  • Deployed regional tracking of biosimilar competitors, timelines and narratives
  • Built scientific defense messaging around patient safety and biocompatibility
  • Positioned biosimilars for naive patients to safeguard existing volume

Impact

  • Successfully delayed biosimilar adoption across major markets
  • Sustained market dominance, core franchise revenues and margins
  • Locked in full-year sales targets well ahead of schedule

Breast Cancer · Oncology

Key Healthcare Partnership

Challenge

  • National market launch against an established standard and a rising competitor
  • Fragmented care views across regional hospital realities
  • Narrow patient perspective focused strictly on clinical and operational needs

Solution

  • Holistic framework integrating clinical, operational and emotional care perspectives
  • Multidisciplinary engagement across HCPs and patient associations
  • National benchmark matrix established to drive local hospital alignment

Impact

  • Differentiated partnership established in metastatic breast cancer
  • Deep operational insight gained into individual hospital realities
  • Accelerated launch readiness and market entry for a key oncology therapy

Solid Tumors · Oncology

All-Year Congress Coverage

Challenge

  • High volume of data readouts requiring rapid analysis during congresses
  • Dispersed competitor updates and fragmented HCP social media sentiment
  • Need for live intelligence to inform medical and strategic decisions

Solution

  • On-site coverage at ESMO BC, ESMO, ASCO and SABCS tracking data readouts, booths and physician sentiment
  • Primary research with KOLs and PIs to evaluate data and competitor trials
  • Daily executive debriefs to adapt medical narrative positioning on site

Impact

  • Accelerated on-site decision-making and strategic narrative adjustments
  • Enabled leadership to respond to competitor updates and data releases
  • Delivered pre-, live- and post-congress intelligence across teams

Prostate Cancer · Oncology

Launch Readiness Plan

Challenge

  • Entering a new therapeutic area
  • Unmapped clinical landscape covering KOLs, centers and treatment flows
  • Need for launch readiness one to two years in advance of market entry

Solution

  • Comprehensive landscape mapping of epidemiology, centers and publications
  • KOL and stakeholder profiling to identify key trial sites and experts
  • Medical Excellence framework to size and structure the field medical team

Impact

  • Achieved early readiness 12 to 18 months prior to therapeutic market entry
  • Optimized medical team sizing aligned with actual market requirements
  • Actionable go-to-market roadmap established for a new therapeutic space

07Where we are

One network, five locations.

  • Lisbon

    Portugal

    Headquarters

  • Zug

    Switzerland

  • Los Angeles

    United States

  • São Paulo

    Brazil

  • Durango

    Mexico